Get the FREE TAVI eGuide NOW!

The FREE TAVI Guide is a comprehensive information kit with everything you need to know about Transcatheter Aortic Valve Implantation (TAVI) treatment option. In this is guide, you will get :

Severe aortic stenosis patients should explore Transcatheter Aortic Valve Implantation (TAVI) treatment options.

Don’t let severe aortic stenosis stop you from living the life you love.

Fill up the form and get your Free TAVI Guide Now.

Download Now

The only effective way to treat severe aortic stenosis is by replacing your valve

This can be done through open heart surgery with incision or a less invasive TAVR procedure.

The only effective way to treat aortic stenosis is by replacing your aortic valve.

Seek treatment early so that you and your loved one can get back to life and all the things you like to do.

Undertand The Heart

By the time severe aortic stenosis is found, the disease has progressed to an advanced stage.

Treatment Options

Taking the next step to find out about available aortic stenosis treatment options may feel overwhelming.


Life After Procedure

What the procedure will be like, what you can expect, and how quickly you can get back to your life.


Affect 1 out of 8

Aortic stenosis is a common condition : affecting about 1 out of 8 people over the age of 75.

* Lancet 2006; 368:1005-11. Burden of valvular heart diseases: a population -based study.

Medicine Won't Cure

It is important to know that medicine cannot stop or cure aortic stenosis – it can only treat symptoms.


50% Chance without Treatment

Without treatment, survival rates in patients with severe aortic stenosis are as low as 50% at two years.

* Heart. 2000;84(2):211-218. Otto, CVALVE DISEASE, Timing of aortic valve surgery.


Learn more about Aortic Stenosis and what you can do next.

Now There is a Less Invasive Procedure That is Designed to Replace Aortic Valve

TAVI is a less invasive procedure that is designed to replace aortic valve and get you back to the activities you love, faster.

Learn more about TAVI and prepare yourself

TAVI Gets You Back To Life Quickly

Don’t let a severe aortic stenosis diagnosis hold you back. Waiting is not an option.

Improved quality of life and relief of symptoms
Shorter hospital stay
Less invasive with minimal scarring
Less pain & anxiety
Better clinical outcomes
Faster  recovery time to getting back to everyday activities

Transcatheter aortic valve replacement (TAVR) gives you a way to live your best life without open heart surgery.

Studies have shown that this less invasive procedure may shorten recovery time, reduce time spent at the hospital and get home quicker.

While each person’s recovery from TAVR may be different, the less invasive TAVR has better clinical outcome following the procedure.

As with any medical procedure, there is a possibility of risks. The most serious risks of TAVI include death, stroke, serious damage to the arteries, or serious bleeding.

Remember, only a TAVI Doctor can determine whether TAVI is an option for you. Ask to be referred to a TAVI Doctor nearest to you.

To find out your nearest TAVI hospital.

Here are What Our Patients and Caregivers Say

Get Your Free TAVI Guide

Important Risk Information ⌵

Information on this site includes educational information regarding certain conditions and potential therapies or treatment options.

Other therapies or treatment options may be available and you should discuss any educational information you access online with your healthcare professional. Appropriate treatment for individuals is a matter for healthcare professionals to decide in consultation with each individual.

Important Risk Information ⌵ Edwards SAPIEN 3 THV System and Edwards SAPIEN 3 Ultra THV System Indications: The Edwards SAPIEN 3 and SAPIEN 3 Ultra Transcatheter Heart Valve system is indicated for relief of aortic stenosis in patients with symptomatic heart disease due to severe native calcific aortic stenosis who are judged by a Heart Team, including a cardiac surgeon, to be appropriate for the transcatheter heart valve replacement therapy. The Edwards SAPIEN 3 and SAPIEN 3 Ultra Transcatheter Heart Valve system is indicated for patients with symptomatic heart disease due to failing (stenosed, insufficient, or combined) of a surgical or transcatheter bioprosthetic aortic valve or surgical bioprosthetic mitral valve who are judged by a heart team, including a cardiac surgeon, to be at high or greater risk for open surgical therapy (i.e., predicted risk of surgical mortality ≥ 8% at 30 days, based on the Society of Thoracic Surgeons (STS) risk score and other clinical co-morbidities unmeasured by the STS risk calculator). Contraindications (Who should not use): The Edwards SAPIEN 3 Transcatheter Heart Valve System and Edwards SAPIEN 3 Ultra Transcatheter Heart Valve System should not be used in patients who: • Cannot tolerate medications that thin the blood or prevent blood clots from forming. • Have an active infection in the heart or elsewhere. Warnings:
  • There may be an increased risk of stroke in transcatheter aortic valve replacement procedures, compared to other standard treatments for aortic stenosis in the high or greater risk population.
  • If an incorrect valve size for your anatomy is used, it may lead to heart injury, valve leakage, movement, or dislodgement.
  • Patients should talk to their doctor if they have significant heart disease, a mitral valve device or are sensitive to cobalt, nickel, chromium, molybdenum, titanium, manganese, silicon, and/or polymeric materials.
  • The Edwards SAPIEN 3 Ultra and SAPIEN 3 valves may not last as long in younger patients, or patients with a disease that results in more calcium in their blood.
  • During the procedure, your doctors should monitor the dye used in the body; if used in excess it could lead to kidney damage. X-ray guidance used during the procedure may cause injury to the skin, which may be painful, damaging, and long-lasting.
  • Patient’s creatinine level should be measured prior to the procedure.
  • Patients who have already had a valve replaced should be carefully assessed by their physician prior to receiving a new valve to ensure proper placement of the new valve.
  • Injury can occur if the delivery system is not used properly.
  • Transcatheter heart valve patients should talk to their physicians about the potential need for medications that thin the blood or prevent blood clots from forming.
Precautions: The long-term durability of the Edwards SAPIEN 3 Ultra and SAPIEN 3 transcatheter heart valves are not known at this time. Regular medical follow-up is recommended to evaluate how well a patient’s heart valve is performing. Limited clinical data are available for transcatheter aortic valve replacement in patients who are born with an aortic heart valve that has only two leaflets and who are determined to be at low risk for open heart surgery. Long-term durability of the valve has not been established. The safety and effectiveness of the transcatheter heart valves are also not known for patients who have:
  • An aortic heart valve that is not calcified, contains only one leaflet, has leaflets with large pieces of calcium that may block the vessels that supply blood to the heart or in which the main problem is that the valve leaks.
  • Previous prosthetic ring in any position.
  • Previous atrial septal occlude.
  • A heart that does not pump well, has thickening of the heart muscle, with or without blockage, unusual ultrasound images of the heart that could represent irregularities such as a blood clot, a diseased mitral valve that is calcified or leaking, or Gorlin syndrome, a condition that affects many areas of the body and increases the risk of developing various cancers and tumors.
  • Low white, red or platelet blood cell counts, or history of bleeding because the blood does not clot properly.
  • Diseased, abnormal or irregularly shaped vessels leading to the heart. Vessels which are heavily diseased or too small for associated delivery devices, or a large amount of calcification at the point of entry.
  • Allergies to blood-thinning medications or dye injected during the procedure. For a valve in valve procedure, there is a risk of leakage if the previously implanted tissue valve is not securely in place or if it is damaged. There is also the possibility that a partially detached valve leaflet from the previously implanted valve could block a blood vessel.
  • Additional pre-procedure imaging will be completed to evaluate proper sizing.
Potential risks associated with the procedure include:
  • Death, stroke, paralysis (loss of muscle function), permanent disability, or severe bleeding.
  • Risks to the heart, including heart attack or heart failure, a heart that does not pump well, irregular heartbeat that may result in a need for a permanent pacemaker, chest pain, heart murmur, false aneurysm, recurring aortic stenosis (narrowing), too much fluid around the heart, injury to the structure of the heart.
  • Risks to your lungs or breathing, including difficulty breathing, fainting, buildup of fluid in or around the lungs, weakness or inability to exercise.
  • Risks involving bleeding or your blood supply, including formation of a blood clot, high or low blood pressure, limited blood supply, a decrease in red blood cells, or abnormal lab values, bleeding in the abdominal cavity, collection of blood under the skin.
  • Additional risks, including life-threatening infection, dislodgement of calcified material, air embolism (air bubbles in the blood vessels), poor kidney function or failure, nerve injury, fever, allergic reaction to anesthesia or dye, reoperation, pain, infection or bleeding at incision sites, or swelling.
Additional potential risks specifically associated with the use of the heart valves include:
  • Valve movement after deployment, blockage or disruption of blood flow through the heart, need for additional heart surgery and possible removal of the Edwards SAPIEN 3 Ultra and SAPIEN 3 valves, a blood clot that requires treatment, damage to the valve (e.g., wear, breakage, recurring aortic stenosis), nonstructural valve dysfunction (e.g., leakage, inappropriate sizing or positioning, blockage, excess tissue in growth, blood cell damage, etc.) or mechanical failure of the delivery system and/or accessories.
CAUTION: Federal (United States) law restricts these devices to sale by or on the order of a physician.

© 2021 Edwards Lifesciences Corporation. All Rights Reserved.

Download FREE TAVI e-Guide Now

Scroll to Top